Pulmonary artery catheterization, also known as SwanGanz catheterization, is the procedure by which a catheter is inserted into the right side of the heart and into the arteries that connect to the lungs. It is used to diagnose problems such as: B. Determine hemodynamic abnormalities in the heart and lungs. This catheter can measure pulmonary artery, right ventricular pressure, and left atrial wedge pressure. Pulmonary artery catheterization can be used to assess the risk of heart attack, shock, heart failure, pulmonary edema, cardiomyopathy, pulmonary hypertension, and is widely used to check for renal complications.
The catheter can be used with IV, which can administer cardiac medication and monitor and verify the efficacy of the medication through a pulmonary artery catheter. Pulmonary artery catheters or SwanGanz catheters can be used in combination with endocardial biopsy. It also helps determine if a drug is needed to lower blood pressure, as heart transplant patients need to lower pulmonary artery pressure.
Get FREE PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/465
Elevated incidence of heart and lung disease is driving the lung catheter market. According to the 2015 WHO report, cardiovascular disease accounted for 31% of all deaths worldwide. The increased incidence of cardiovascular disease creates a highly encouraging environment for the global pulmonary artery catheter market to grow. The high prevalence of diabetes, high blood pressure due to lifestyle changes, and smoking and drinking habits continue to support market growth.
The growing elderly population worldwide is driving the global pulmonary artery catheter market. However, the use of pulmonary artery catheters has some limitations as it is not recommended for routine management of patients with acute respiratory distress syndrome, septic shock, and patients at high risk of surgery. The most dangerous risks associated with the use of pulmonary artery catheters are those for patients undergoing pulmonary artery rupture and anticoagulant therapy. An increasing number of cardiac clinics worldwide is expected to spur growth in the global pulmonary artery catheter market.
The rapid use of pulmonary artery catheters by clinicians is expected to support the growth of the global pulmonary artery catheter market.
By Product Type,
Six lumen catheter
Four lumen catheter
Five limen catheter
Get Sample Report with Latest Covid19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/465
By End User,
Ambulatory surgical centers
North America dominates the global pulmonary artery catheter market, primarily due to the high prevalence of sedentary cardiovascular disease. Lifestyle changes, unhealthy eating habits, an increase in the number of people with habits such as smoking and drinking, and an increase in stress levels due to an increase in the patient population will lead to the growth of the global pulmonary artery catheter market. It is also one of the emerging markets for pulmonary artery catheters, following North America, Europe, and the Asia Pacific region. Lifestyle changes, sedentary lifestyles, and an increasing elderly population in the region are some of the factors propelling the scope of the global pulmonary artery catheter market in the region.
Major companies contributing to the global pulmonary artery catheter market include Edwards Life Sciences Corporation, argon Medical, ICU Medical, Becton, Dickinson and Company (BD), and Biosensors International.
Purchase This Premium Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/465
Table of Content
Global Pulmonary Artery Catheters Market Research Report
Section 1: Global Pulmonary Artery Catheters Industry Overview
Section 2: Global Economic Impact on Pulmonary Artery Catheters Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Pulmonary Artery Catheters Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Pulmonary Artery Catheters Market Forecast
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027